LEMAITRE VASCULAR INC — Director's Dealing 2025

Dec 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-12-12

Reporting Person: Roush John A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-12	Common Stock	M	5	—	Acquired	3460	Direct
2025-12-12	Common Stock	M	5	—	Acquired	3465	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-12	Dividend Equivalent Rights	$	M	5	Disposed		Common Stock (5)	Direct
2025-12-12	Dividend Equivalent Rights	$	M	5	Disposed		Common Stock (5)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	181	Indirect

Footnotes

F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero.

F4: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.